Cargando…
Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor
Tenosynovial giant cell tumor is a neoplastic disease of joints that can cause severe morbidity. Recurrences are common following local therapy, and no effective medical therapy currently exists. Recent work has demonstrated that all cases overexpress macrophage colony-stimulating factor (CSF1), usu...
Autores principales: | Cheng, Hongwei, Clarkson, Paul W., Gao, Dongxia, Pacheco, Marina, Wang, Yuzhuo, Nielsen, Torsten O. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957133/ https://www.ncbi.nlm.nih.gov/pubmed/20981142 http://dx.doi.org/10.1155/2010/174528 |
Ejemplares similares
-
Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors
por: van IJzendoorn, David G.P., et al.
Publicado: (2022) -
Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages
por: Smith, Bryan D., et al.
Publicado: (2021) -
Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
por: Mastboom, Monique J L, et al.
Publicado: (2018) -
Molecular Profiling of Atypical Tenosynovial Giant Cell Tumors Reveals Novel Non-CSF1 Fusions
por: Vougiouklakis, Theodore, et al.
Publicado: (2019) -
Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2014)